Promazina en es it fr

Promazina Brand names, Promazina Analogs

Promazina Brand Names Mixture

  • No information avaliable

Promazina Chemical_Formula

C17H20N2S

Promazina RX_link

No information avaliable

Promazina fda sheet

Promazina msds (material safety sheet)

Promazina Synthesis Reference

No information avaliable

Promazina Molecular Weight

284.42 g/mol

Promazina Melting Point

< 25 oC

Promazina H2O Solubility

14.2 mg/L

Promazina State

Liquid

Promazina LogP

4.893

Promazina Dosage Forms

Tablet; Oral liquid; Injection

Promazina Indication

Used as an adjunct for short term treatment of moderate and severe psychomotor agitation. Also used to treat agitation or restlessness in the elderly.

Promazina Pharmacology

Promazine belongs to a group of medications known as the phenothiazine antipsychotics. It acts by blocking a variety of receptors in the brain, particularly dopamine receptors. Dopamine is involved in transmitting signals between brain cells. When there is an excess amount of dopamine in the brain it causes over-stimulation of dopamine receptors. These receptors normally act to modify behaviour and over-stimulation may result in psychotic illness. Promazine hydrochloride blocks these receptors and stops them becoming over-stimulated, thereby helping to control psychotic illness. Promazine has weak extrapyramidal and autonomic side effects which lead to its use in the elderly, for restless or psychotic patients. Its anti-psychotic effect is also weaker and it is not useful in general psychiatry.

Promazina Absorption

Absorption may be erratic and peak plasma concentrations show large interindividual differences.

Promazina side effects and Toxicity

Side effects include: extrapyramidal symptoms, drowsiness, weight gain, dry mouth, constipation, endocrine effects (such as gynaecomastia and menstrual disturbance), sensitivity to sunlight and haemolytic anaemia.

Promazina Patient Information

No information avaliable

Promazina Organisms Affected

Humans and other mammals